Target intelligence / Profile preview

ribosomal protein L22 pseudogene 11 (RPL22P11)

Target: RPL22P11
Molecular classification: Other (Pseudogene)

Overview

RPL22P11 is a processed pseudogene belonging to the ribosomal protein L22 family. Pseudogenes are non-functional segments of DNA that resemble functional genes but typically lack the ability to encode proteins due to mutations or truncations. RPL22P11 is neither expressed as a protein nor implicated in any known biological function or disease process. Pseudogenes like RPL22P11 may arise from duplication or retrotransposition events of their parent genes—in this case, the functional RPL22 gene[2].

Other names: RPL22P15RPL22P9RPL22_3_260[2]

Beyond the preview

Go deeper on ribosomal protein L22 pseudogene 11 (RPL22P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L22 pseudogene 11 (RPL22P11).

Explore the full profile